当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Ioan Mayer
This Biopharmaceutics introduces abecedarian generalities, styles, and advances in the areas of dissolution, immersion, and permeability and their crucial operations in lozenge form performance. Case studies are used to bandy the operations of biopharmaceutic strategies in the development of successful medicines, with a specific focus on the operations of biopharmaceutic strategies in the development of successful medicines. The book presents an intertwined view in linking pharmaceutic to the natural consequences of medicine products and leverages those for decision making in medicine development. The Biopharmaceutics Bracket System (BCS) isn't only a useful tool for carrying quitclaims for in- vivo bioequivalence studies but also for decision making in the discovery and early development of new drugs. Biopharmaceutics is a major branch in pharmaceutical lores which relates between the physicochemical parcels of a drug in capsule form and the pharmacology, toxicology, or clinical response observed after its administration. Drug effectiveness and safety are dependent on the dosing authority. The optimal capsule and dosing intervals can be fairly different for different drugs. Also, for a single drug, the optimal capsule can be different considerably between cases.